CEACAM5 and neoplasm: This process involves antibodies against carcinoembryonic antigen (CEA) on macrophages binding to the Fc region of CEA antibodies on cancer cells, thereby inducing antibody-dependent cellular cytotoxicity (ADCC) to eliminate CEA-expressing tumor cells.